Labeler
Accord BioPharma Inc. NDC Codes
Accord BioPharma Inc. lists 16 finished drug products in the FDA NDC Directory under NDC labeler code 69448.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Active ingredients
- Pegfilgrastim, Ustekinumab-srlf, Filgrastim, Denosumab, Leuprolide mesylate, Trastuzumab-strf, Mitomycin
- NDC labeler codes
- 69448
- Strengths
- Pegfilgrastim 6 mg/.6mL; Leuprolide mesylate 42 mg/.37g; Filgrastim 480 ug/.8mL; Denosumab 70 mg/mL; Denosumab 60 mg/mL; Filgrastim 300 ug/.5mL; Trastuzumab-strf 150 mg/7.4mL; Trastuzumab-strf 420 mg/20mL; Ustekinumab-srlf 130 mg/26mL; Ustekinumab-srlf 45 mg/.5mL; Ustekinumab-srlf 90 mg/mL; Mitomycin 5 mg/10mL; Mitomycin 40 mg/80mL
- Dosage forms
- Injection, Solution, Injection, Injection, Powder, Lyophilized, For solution, Injection, Emulsion
- Routes
- Subcutaneous, Intravenous
- Drug classes (FDA established)
- Leukocyte Growth Factor, Interleukin-12 Antagonist, Interleukin-23 Antagonist, RANK Ligand Inhibitor, Gonadotropin Releasing Hormone Receptor Agonist, HER2/neu Receptor Antagonist, Alkylating Drug
- HCPCS / J-code
- J0897 — Injection, denosumab, 1 mg, J2506 — Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
- Package NDCs
- 18
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Filkrifilgrastim-laha | Filgrastim 480 ug/.8mL | Injection, SolutionIntravenous, Subcutaneous | 69448-009 | 69448-0009-0369448-0009-63 | — |
| Jubereqdenosumab-desu | Denosumab 70 mg/mL | InjectionSubcutaneous | 69448-022 | 69448-0022-63 | J0897 |
| Osvyrtidenosumab-desu | Denosumab 60 mg/mL | InjectionSubcutaneous | 69448-021 | 69448-0021-63 | J0897 |
| Filkrifilgrastim-laha | Filgrastim 300 ug/.5mL | Injection, SolutionIntravenous, Subcutaneous | 69448-008 | 69448-0008-0369448-0008-63 | — |
| Udenycapegfilgrastim-cbqv | Pegfilgrastim 6 mg/.6mL | Injection, SolutionSubcutaneous | 69448-026 | 69448-0026-63 | J2506 |
| Udenycapegfilgrastim-cbqv | Pegfilgrastim 6 mg/.6mL | Injection, SolutionSubcutaneous | 69448-025 | 69448-0025-63 | J2506 |
| Udenycapegfilgrastim-cbqv | Pegfilgrastim 6 mg/.6mL | Injection, SolutionSubcutaneous | 69448-027 | 69448-0027-63 | J2506 |
| Camcevileuprolide | Leuprolide mesylate 42 mg/.37g | Injection, EmulsionSubcutaneous | 69448-023 | 69448-0023-63 | — |
| Hercessitrastuzumab-strf | Trastuzumab-strf 150 mg/7.4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 69448-015 | 69448-0015-05 | — |
| Hercessitrastuzumab-strf | Trastuzumab-strf 420 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 69448-016 | 69448-0016-11 | — |
| Imuldosaustekinumab-srlf | Ustekinumab-srlf 130 mg/26mL | InjectionIntravenous | 69448-019 | 69448-0019-26 | — |
| Imuldosaustekinumab-srlf | Ustekinumab-srlf 45 mg/.5mL | InjectionSubcutaneous | 69448-017 | 69448-0017-63 | — |
| Imuldosaustekinumab-srlf | Ustekinumab-srlf 90 mg/mL | InjectionSubcutaneous | 69448-018 | 69448-0018-63 | — |
| Camcevileuprolide | Leuprolide mesylate 42 mg/.37g | Injection, EmulsionSubcutaneous | 69448-014 | 69448-0014-63 | — |
| Mutamycinmitomycin | Mitomycin 5 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 69448-001 | 69448-0001-05 | — |
| Mutamycinmitomycin | Mitomycin 40 mg/80mL | Injection, Powder, Lyophilized, For solutionIntravenous | 69448-003 | 69448-0003-38 | — |
Accord BioPharma Inc.: common questions
- What is Accord BioPharma Inc.'s NDC labeler code?
- 69448. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Accord BioPharma Inc.?
- Med-Code's HCPCS directory matches J0897, J2506 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.